Neuronal and Glial YAP/TAZ in the Spinal Cord Contribute to the Development of Bone Cancer Pain in Mice
- Neurosci Bull. 2026 Mar 22. doi: 10.1007/s12264-026-01607-4.
- 1. Department of Medical Neuroscience, School of Medicine, Southern University of Science and Technology, Shenzhen, 518055, China.
- 2. SUSTech Center for Pain Medicine, School of Medicine, Southern University of Science and Technology, Shenzhen, 518055, China.
- 3. Queensland Brain Institute, The University of Queensland, Brisbane, 4072, Australia.
- 4. Department of Medical Neuroscience, School of Medicine, Southern University of Science and Technology, Shenzhen, 518055, China. [email protected].
- 5. SUSTech Center for Pain Medicine, School of Medicine, Southern University of Science and Technology, Shenzhen, 518055, China. [email protected].
- # Contributed equally.
The treatment of bone Cancer pain (BCP) remains a major clinical challenge, and the mechanisms underlying BCP remain poorly understood. Here, we report that tumor cell implantation (TCI) led to nuclear accumulation of yes-associated protein (YAP) and transcriptional coactivator with PDZ (postsynaptic density protein 95, PSD-95; discs large, Dlg; zonula occludens-1, ZO-1)-binding motif (TAZ) and up-regulation of their mRNA (messenger ribonucleic acid) expression in Vglut2+ excitatory neurons, microglia, and astrocytes in the spinal dorsal horn. Pharmacological inhibition of YAP/TAZ or genetic knockout of YAP/TAZ in Vglut2+ excitatory neurons, microglia, or astrocytes significantly alleviates TCI-induced BCP. Mechanistically, ablation of YAP/TAZ in Vglut2+ excitatory neurons suppressed TCI-induced hyperexcitability of the dorsal horn neurons via β-catenin signaling modulation; concurrently, deletion of YAP/TAZ in microglia and astrocytes prevented TCI-induced activation of these glial cells and decreased levels of proinflammatory cytokines through regulation of nuclear factor kappa-B (NF-κB) signaling. The present study reveals the vital roles of spinal YAP/TAZ in the pathogenesis of BCP and identifies a potential molecular target for therapeutic intervention in BCP.